That's a great find and a good read, so I thought I'll look a bit into the author of that article. He seems to be highly regarded and well connected individual.
His comments about the KMP are quite interesting.
Fully Operational?
Supplying Korean and other customers?
Considering licensing their advanced technologies to allied partners?
If all true, these are things we have not heard from ASM. Maybe we should send an email and ask for some clarifications?About
Dr. Laird is a military and security analyst. He has published more than 30 books and many articles on defense, space and security issues in Asia, Europe and the United States. He is the co-founder of Second Line of Defense where the core analytical team publishes regularly on global affairs (http://www.sldinfo.com or on http://www.sldforum.com) and has launched a new website, defense.info as well.
He is on the editorial advisory board of Breaking Defense and is a regular contributor. He writes regularly for the leading Canadian defense journal Front Line Defense. He works the Canberra-based Williams Foundation and provides regular reports on the transformation of Australian forces. Second Line of Defense is partnered with a number of global publications including defenceWeb, India Strategic and many others.
He travels regularly to Europe and Asia and provides regular assessments of evolving policies, strategies and technologies in Asia and Europe as well providing assessments of evolving threats to those forces for various clients.
He is currently focusing his research on the transformation of Nordic defense and of North Atlantic defense from the UK through the Baltics.
Recently, he was appoint a Research Fellow with the Williams Foundation in Canberra Australia.
- Forums
- ASX - By Stock
- ASM
- Relevant Media
ASM
australian strategic materials limited
Add to My Watchlist
2.88%
!
50.5¢

Relevant Media, page-1760
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
50.5¢ |
Change
-0.015(2.88%) |
Mkt cap ! $91.57M |
Open | High | Low | Value | Volume |
52.5¢ | 54.0¢ | 50.5¢ | $210.6K | 401.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 28242 | 50.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
52.0¢ | 778 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 20000 | 0.505 |
13 | 143900 | 0.500 |
3 | 9020 | 0.495 |
2 | 12600 | 0.490 |
2 | 2100 | 0.480 |
Price($) | Vol. | No. |
---|---|---|
0.520 | 778 | 1 |
0.525 | 10000 | 1 |
0.535 | 58947 | 2 |
0.540 | 26826 | 4 |
0.545 | 2756 | 2 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
ASM (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online